New sedative may make lung exams safer and smoother
NCT ID NCT07184801
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether dexmedetomidine, a sedative, works better than midazolam for keeping patients comfortable during medical thoracoscopy—a procedure where doctors look inside the chest cavity. About 56 adults with unexplained fluid around the lungs will be randomly assigned to receive one of the two drugs. The goal is to see if dexmedetomidine reduces the need for extra pain medicine, shortens recovery time, and lowers the risk of complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Dexmedetomidine (a sedative drug)
- What this could lead to
- If it works, this could point toward a better sedation option for lung procedures, making them safer and more comfortable for patients.
- What could go wrong
- This is a small, early-phase trial with only 56 participants, so results may not apply to everyone. Both drugs have known side effects like low blood pressure or slow heart rate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICAL THORACOSCOPY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bronchoscopy suite
RECRUITINGChandigarh, Chandigarh, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.